Improvement of side-effects and treatment on the experimental colitis in mice of a resin microcapsule-loading hydrocortisone sodium succinate

References

• Monteleone G, Pallone F, MacDonald TT. Emerging immunological targets in inflammatory bowel disease. Curr Opin Pharmacol 2011;11:640–5.
   PubMed Web of Science ®Google Scholar
• Blonski W, Buchner AM, Lichtenstein GR. Treatment of ulcerative colitis. Curr Opin Gastroenterol 2014;30:84–96.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab. Ther Clin Risk Manag 2013;9:451–6.
   PubMed Web of Science ®Google Scholar
• Meier J, Sturm A. Current treatment of ulcerative colitis. World J Gastroenterol: WJG 2011;17:3204–12.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2:1041–8.
   PubMed Web of Science ®Google Scholar
• Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270:283–6.
   PubMed Web of Science ®Google Scholar
• Tao YX, Williams-Skipp C, Scheinman RI. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J Biol Chem 2001;276:2329–32.
   PubMed Web of Science ®Google Scholar
• Farup PG, Hovde O, Halvorsen FA, et al. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis – a comparison of the efficacy and practicality of 2 topical treatment regimens. Scand J Gastroenterol 1995;30:164–70.
   PubMed Web of Science ®Google Scholar
• Meyers S, Sachar DB, Goldberg JD, Janowitz HD. Conrticotropin versus hydrocotisone in intravenous treatment of ulcerative colitis – a prospective, randomized, double-blind clinical-trial. Gastroenterology 1983;85:351–7.
   PubMed Web of Science ®Google Scholar
• Ruddell WSJ, Dickinson RJ, Dixon MF, Axon ATR. Treatment of distal ulcerative-colitis (proctosigmoiditis) in relapse – comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 1980;21:885–9.
   PubMed Web of Science ®Google Scholar
• Sadahiro S, Ito Z, Iijima T, et al. Pharmaceutical characterization of corticosteroid suppository treatment for ulcerative colitis. Digest Dis Sci 1992;37:1898–902.
   PubMed Web of Science ®Google Scholar
• Danielsson A. Treatment of distal ulcerative colitis with nonsystemic corticosteroid enemas. Scand J Gastroenterol 1996;31:945–53.
   PubMed Web of Science ®Google Scholar
• Miyata M, Kasugai K, Ishikawa T, et al. Rebamipide enemas – new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis. Digest Dis Sci 2005;50:S119–23.
   Web of Science ®Google Scholar
• Halverstam CP, Vachharajani A, Mallory SB. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome. Pediatr Dermatol 2007;24:42–5.
   PubMed Web of Science ®Google Scholar
• Rohr SB, Sauer H, Gortner L, et al. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience. Acta Paediatr 2013;102:e436. doi: 10.1111/apa.12338.
   Google Scholar
• Zhao J, Cui Y, Wang AH, et al. Side effect reduction of encapsulated hydrocortisone crystals by insulin/alginate shells. Langmuir: ACS J Surf Colloids 2011;27:1499–504.
   PubMed Web of Science ®Google Scholar
• Karavitaki N, Taylor AE, Kohler S, et al. Hydrocortisone administration for prevention of adrenal crisis in stress – pharmacokinetics of different administration modes in adrenal insufficiency and comparison to surgical stress. Endocr Rev 2010;31.
   Web of Science ®Google Scholar
• Das S, Subuddhi U. Controlled delivery of dexamethasone to the intestine from poly(vinyl alcohol)-poly(acrylic acid) microspheres containing drug-cyclodextrin complexes: influence of method of preparation of inclusion complex. Rsc Adv 2014;4:24222–31.
   Web of Science ®Google Scholar
• Dong K, Dong Y, You C, et al. Assessment of the safety, targeting, and distribution characteristics of a novel pH-sensitive hydrogel. Colloids Surf B Biointerfaces 2014;123:965–73.
   PubMed Web of Science ®Google Scholar
• Eroglu H, Kas HS, Oner L, et al. The in-vitro and in-vivo characterization of PLGA:L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsul 2001;18:603–12.
   PubMed Web of Science ®Google Scholar
• Kopacz DJ, Bernards CM, Allen HW, et al. A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules. Anesth Analg 2003;97:124–31.
   PubMed Web of Science ®Google Scholar
• Amsel LP, Hinsvark ON. Recent advances in sustained-release technology using ion-exchange polymer. Pharm Technol 1984;4:28–34.
   Google Scholar
• Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today 2001;6:905–14.
   PubMed Web of Science ®Google Scholar
• Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci 2009;98:3886–902.
   PubMed Web of Science ®Google Scholar
• Burton S, Washington N, Steele RJC, et al. Intragastric distribution of ion-exchange resins: a drug delivery system for the topical treatment of the gastric mucosa. J Pharm Phamacol 1995;47:901–6.
   PubMed Web of Science ®Google Scholar
• Jaskari T, Vuorio M, Kontturi K, et al. Controlled transdermal iontophoresis by ion-exchange fiber. J Control Release: Off J Control Release Soc 2000;67:179–90.
   PubMed Web of Science ®Google Scholar
• Jeong SH, Park K. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 2008;353:195–204.
   PubMed Web of Science ®Google Scholar
• Narisawa S, Nagata M, Danyoshi C, et al. An organic acid induced sigmoidal release system for oral controlled release preparations. Pharm Res 1994;11:111–16.
   PubMed Web of Science ®Google Scholar
• Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, et al. Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin. AAPS PharmSciTech 2013;14:1118–28.
   PubMed Web of Science ®Google Scholar
• Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 2004;30:429–48.
   PubMed Web of Science ®Google Scholar
• Yewale CP, Rathi MN, Kore GG, et al. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins. Pharm Dev Technol 2013;18:367–76.
   PubMed Web of Science ®Google Scholar
• Yu L, Li S, Yuan Y, et al. The delivery of ketoprofen from a system containing ion-exchange fibers. Int J Pharm 2006;319:107–13.
   PubMed Web of Science ®Google Scholar
• Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2001;281:G586–94.
   PubMed Web of Science ®Google Scholar
• Patel SH, Rachchh MA, Jadav PD. Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease. Indian J Pharmacol 2012;44:744–8.
   PubMed Web of Science ®Google Scholar
• Xu L, Yang ZL, Li P, Zhou YQ. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine 2009;16:989–95.
   PubMed Web of Science ®Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm 2008;363:26–39.
   PubMed Web of Science ®Google Scholar
• Dong K, Zeng AG, Wang ML, et al. In vitro and in vivo study of a colon-targeting resin microcapsule loading a novel prodrug, 3,4,5-tributyryl shikimic acid. Rsc Adv 2016;6:16882–90.
   Web of Science ®Google Scholar
• Zeng A, Dong K, Wang M, et al. Investigation of the colon-targeting, improvement on the side-effects and therapy on the experimental colitis in mouse of a resin microcapsule loading dexamethasone sodium phosphate. Drug Deliv 2016;23:1992–2002.
   PubMed Web of Science ®Google Scholar
• McCabe AJ, Dowhy M, Holm BA, Glick PL. Myeloperoxidase activity as a lung injury marker in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg 2001;36:334–7.
   PubMed Web of Science ®Google Scholar
• Guilpain P, Le Jeunne C. Anti-inflammatory and immunosuppressive properties of corticosteroids. Presse Med 2012;41:378–83.
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA-J Am Med Assoc 2009;301:2362–75.
   PubMed Web of Science ®Google Scholar
• Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002;113:59–65.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J 1954;2:375–8.
   PubMed Web of Science ®Google Scholar
• Lennardjones JE. Toward optimal use of corticosteroids in ulcerative-colitis and Crohns-disease. Gut 1983;24:177–81.
   PubMed Web of Science ®Google Scholar
• Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007;5:103–10.
   PubMed Web of Science ®Google Scholar
• De Cassan C, Fiorino G, Danese S. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects? Dig Dis 2012;30:368–75.
   PubMed Web of Science ®Google Scholar
• Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 2006;100:1307–17.
   PubMed Web of Science ®Google Scholar
• Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001;33:289–94.
   PubMed Web of Science ®Google Scholar
• Benrhouma K, Sakly M. Involution of rat thymus: characterization of cytoplasmic glucocorticoid receptors, evidence of glucocorticoid resistant dexamethasone receptor-positive cells. Arch Int Physiol Biochim Biophys 1994;102:97–102.
   PubMedGoogle Scholar
• Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004;309:249–58.
   PubMed Web of Science ®Google Scholar